Roth Capital Lowers Earnings Estimates for Aurora Cannabis

Aurora Cannabis Inc. (NASDAQ:ACB) – Equities research analysts at Roth Capital reduced their Q4 2025 earnings per share estimates for Aurora Cannabis in a report issued on Thursday, February 6th. Roth Capital analyst W. Kirk now anticipates that the company will post earnings of $0.27 per share for the quarter, down from their prior estimate of $0.40. The consensus estimate for Aurora Cannabis’ current full-year earnings is ($0.10) per share. Roth Capital also issued estimates for Aurora Cannabis’ FY2026 earnings at $0.88 EPS.

Aurora Cannabis (NASDAQ:ACB) last posted its quarterly earnings data on Wednesday, February 5th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of ($0.09) by $0.15. Aurora Cannabis had a return on equity of 0.59% and a net margin of 0.42%.

ACB has been the topic of a number of other reports. TD Cowen assumed coverage on shares of Aurora Cannabis in a research note on Wednesday, December 11th. They set a “buy” rating on the stock. Atb Cap Markets raised shares of Aurora Cannabis from a “hold” rating to a “strong-buy” rating in a report on Wednesday, February 5th. Finally, TD Securities raised Aurora Cannabis to a “strong-buy” rating in a research note on Thursday, December 12th.

Aurora Cannabis Price Performance

Shares of NASDAQ:ACB opened at $6.42 on Monday. Aurora Cannabis has a 52 week low of $2.84 and a 52 week high of $9.35. The company has a 50-day moving average price of $4.35 and a 200 day moving average price of $5.16. The company has a market cap of $352.20 million, a P/E ratio of 128.43 and a beta of 1.84. The company has a quick ratio of 1.88, a current ratio of 3.30 and a debt-to-equity ratio of 0.07.

Institutional Investors Weigh In On Aurora Cannabis

Several hedge funds have recently modified their holdings of ACB. SBI Securities Co. Ltd. purchased a new position in shares of Aurora Cannabis in the 4th quarter worth $31,000. Cubist Systematic Strategies LLC acquired a new stake in Aurora Cannabis during the second quarter worth about $50,000. Wealthspire Advisors LLC purchased a new position in shares of Aurora Cannabis in the 4th quarter worth about $149,000. Finally, Tidal Investments LLC lifted its stake in shares of Aurora Cannabis by 2.7% in the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company’s stock valued at $7,905,000 after purchasing an additional 34,988 shares in the last quarter. 47.63% of the stock is owned by institutional investors and hedge funds.

About Aurora Cannabis

Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.